Tai-Ling Biotech Inc. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 183.926 million compared to TWD 155.630 million a year ago. Operating income was TWD 12.090 million compared to TWD 1.737 million a year ago. Net income was TWD 9.243 million compared to TWD 2.472 million a year ago. Basic earnings per share was TWD 0.26 compared to TWD 0.07 a year ago.